Diagnosis and Treatment of Polymyalgia Rheumatica |
Seokchan Hong, Yong-Gil Kim |
Division of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
류마티스 다발근통의 진단과 치료 |
홍석찬, 김용길 |
울산대학교 의과대학 서울아산병원 류마티스내과 |
Correspondence:
Yong-Gil Kim, Tel: +82-2-3010-3279, Fax: +82-2-3010-6969, Email: bestmd2000@amc.seoul.kr |
|
|
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits
unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Abstract |
Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder that usually affects adults over 50 years of age. It is characterized
by pain and stiffness of the neck, shoulders and hips. Laboratory tests have shown marked elevation of acute phase reactants
(ESR and CRP), but there is no specific test to diagnose PMR. Recently, the European League Against Rheumatism and the
American College of Rheumatology jointly proposed a new set of classification criteria for PMR. The mainstay of PMR treatment
is low-dose glucocorticoids (prednisolone 10-20 mg/day). patients with PMR usually respond very well to steroid therapy within a
few days to one week, but will often relapse despite treatment. |
|